Location History:
- Stamford, CT (US) (2006)
- Waltham, MA (US) (2007 - 2016)
- Newton, MA (US) (2023 - 2024)
Company Filing History:
4 out of 764 
2 out of 762 
Years Active: 2006-2024
Title: The Innovative Contributions of Spyridon P Nikas
Introduction
Spyridon P Nikas is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cannabinoid research, holding a total of 7 patents. His work focuses on the modulation of cannabinoid receptors and the development of compounds that can be used in various therapeutic applications.
Latest Patents
Among his latest patents, one is titled "Cannabinergic compounds and uses thereof." This patent discloses compounds and compositions that modulate cannabinoid receptors, along with methods for treating disorders related to these receptors. The conditions addressed include cannabinoid dependence, neuropathy, inflammation, glaucoma, neurodegenerative disorders, motor function disorders, gastrointestinal disorders, hypothermia, emesis, loss of appetite, and anorexia associated with AIDS. Another significant patent is "Labelled cannabinergic ligands and related analogs." This patent introduces novel cannabinoid ligands and methods for their preparation and use. The compounds can bind to and modulate the cannabinoid CB1 and CB2 receptors, exhibiting tight or irreversible binding characteristics. These compounds may serve as useful imaging and diagnostic tools, as well as therapeutic agents.
Career Highlights
Spyridon P Nikas has worked at prestigious institutions such as the University of Connecticut and Northeastern University. His research has contributed to advancements in cannabinoid science and its applications in medicine.
Collaborations
Throughout his career, he has collaborated with notable individuals in the field, including Alexandros Makriyannis and Atmaram Khanolkar. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Spyridon P Nikas is a prominent figure in cannabinoid research, with a focus on developing innovative compounds for therapeutic use. His contributions have the potential to significantly impact the treatment of various medical conditions.